• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西女性乳腺癌患者从诊断到开始治疗的时间延迟的决定因素。

Determinants of delay from cancer diagnosis to treatment initiation in a cohort of brazilian women with breast cancer.

机构信息

Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.

Rio de Janeiro State Federal University (UNIRIO), Rio de Janeiro, Brazil.

出版信息

Health Soc Care Community. 2021 Nov;29(6):1769-1778. doi: 10.1111/hsc.13284. Epub 2021 Jan 13.

DOI:10.1111/hsc.13284
PMID:33438787
Abstract

This objective this study was to identify the time interval between breast cancer (BC) diagnosis and treatment initiation and delay-associated factors. This is a prospective cohort study that followed breast cancer patients, enrolled and treated at the cancer center in Rio de Janeiro (RJ) - Brazil, from October 02, 2014 to April 30, 2015. Participants were interviewed at the first consultation. Treatment-related information was collected six months after recruitment. The median and interquartile range (IQR) were calculated. The interval between breast cancer diagnosis and treatment initiation of more than 60 days was considered the delay, according to the maximum term determined by Brazilian law. The association between independent variables and the outcome was performed using the crude odds ratios (OR). Variables presenting p < .20 in the univariate analysis were included in the multiple logistic regression model by the stepwise forward method, and those with p < .05 were retained in the final model. A total of 470 patients were included in the study. The median time was of 127 days (IQR: 85- 174). Delay was observed in 89.1% of the cases. After adjustment, the variables associated with delay were age ≥ 60 years (OR: 2.48; 95% CI 1.22-5.06), initial clinical staging (<2B) (OR: 2.01; 95% CI 1.05-3.86) and residence outside the city of Rio de Janeiro (OR: 2.75; 95% CI 1.38-5.51). Delays in starting treatment were associated with sociodemographic and clinical factors. Improving patient quality of care and restructuring the health service can minimise delays.

摘要

本研究旨在确定乳腺癌(BC)诊断与治疗开始之间的时间间隔以及与延迟相关的因素。这是一项前瞻性队列研究,对 2014 年 10 月 2 日至 2015 年 4 月 30 日在巴西里约热内卢癌症中心招募和治疗的乳腺癌患者进行了随访。参与者在首次就诊时接受了访谈。在招募后六个月收集与治疗相关的信息。计算了中位数和四分位距(IQR)。根据巴西法律规定的最长期限,将乳腺癌诊断与治疗开始之间超过 60 天的时间间隔定义为延迟。使用未经调整的优势比(OR)对独立变量与结局之间的关联进行了分析。在单因素分析中 p 值<0.20 的变量被纳入逐步向前的多因素逻辑回归模型,p 值<0.05 的变量被保留在最终模型中。共纳入 470 例患者。中位时间为 127 天(IQR:85-174)。89.1%的病例存在延迟。调整后,与延迟相关的变量为年龄≥60 岁(OR:2.48;95%CI 1.22-5.06)、初始临床分期(<2B)(OR:2.01;95%CI 1.05-3.86)和居住地不在里约热内卢市(OR:2.75;95%CI 1.38-5.51)。开始治疗的延迟与社会人口学和临床因素有关。改善患者的护理质量和重构卫生服务可以将延迟降到最低。

相似文献

1
Determinants of delay from cancer diagnosis to treatment initiation in a cohort of brazilian women with breast cancer.巴西女性乳腺癌患者从诊断到开始治疗的时间延迟的决定因素。
Health Soc Care Community. 2021 Nov;29(6):1769-1778. doi: 10.1111/hsc.13284. Epub 2021 Jan 13.
2
Factors influencing delay in symptomatic presentation of breast cancer in Brazilian women.影响巴西女性乳腺癌症状表现延迟的因素。
Health Soc Care Community. 2019 Nov;27(6):1525-1533. doi: 10.1111/hsc.12823. Epub 2019 Aug 5.
3
Delay in breast cancer diagnosis: a Brazilian cohort study.乳腺癌诊断延迟:巴西队列研究。
Public Health. 2019 Feb;167:88-95. doi: 10.1016/j.puhe.2018.10.012. Epub 2019 Jan 12.
4
Cervical Cancer Treatment Delays and Associated Factors in a Cohort of Women From a Developing Country.发展中国家一组女性的宫颈癌治疗延误及相关因素
J Glob Oncol. 2019 Jan;5:1-11. doi: 10.1200/JGO.18.00199.
5
Factors Associated with Diagnostic Delays among Tunisian Breast Cancer Patients.与突尼斯乳腺癌患者诊断延迟相关的因素。
Asian Pac J Cancer Prev. 2023 Feb 1;24(2):471-477. doi: 10.31557/APJCP.2023.24.2.471.
6
Time Taken for Symptom Recognition, First Consultation, Diagnosis and First Definitive Treatment and Its Associated Factors among Women with Breast Cancer.女性乳腺癌患者症状识别、首次就诊、诊断和首次确定性治疗所需时间及其相关因素。
Asian Pac J Cancer Prev. 2021 Nov 1;22(11):3623-3631. doi: 10.31557/APJCP.2021.22.11.3623.
7
Delays in presentation, diagnosis, and treatment in Sudanese women with breast cancer: a cross-sectional study.苏丹女性乳腺癌患者就诊、诊断和治疗延误的横断面研究。
Oncologist. 2024 Jun 3;29(6):e771-e778. doi: 10.1093/oncolo/oyae066.
8
[Determinants of patient and health system delays for women with breast cancer in Morocco, 2013].[2013年摩洛哥乳腺癌女性患者及卫生系统延误的决定因素]
Rev Epidemiol Sante Publique. 2015 Jun;63(3):191-201. doi: 10.1016/j.respe.2015.03.121. Epub 2015 May 11.
9
Factors associated with delayed diagnosis of pulmonary tuberculosis in the state of Rio de Janeiro, Brazil.与巴西里约热内卢州肺结核延迟诊断相关的因素。
J Bras Pneumol. 2011 Jul-Aug;37(4):512-20. doi: 10.1590/s1806-37132011000400014.
10
Geospatial barriers to healthcare access for breast cancer diagnosis in sub-Saharan African settings: The African Breast Cancer-Disparities in Outcomes Cohort Study.撒哈拉以南非洲地区乳腺癌诊断中获得医疗保健的地理空间障碍:非洲乳腺癌-结局差异队列研究。
Int J Cancer. 2021 May 1;148(9):2212-2226. doi: 10.1002/ijc.33400. Epub 2020 Dec 8.

引用本文的文献

1
Barriers to breast cancer treatment in Brazil: A study on migration and regional disparities.巴西乳腺癌治疗的障碍:一项关于移民与地区差异的研究。
Public Health Pract (Oxf). 2025 May 13;9:100614. doi: 10.1016/j.puhip.2025.100614. eCollection 2025 Jun.
2
Quantifying the impact of treatment delays on breast cancer survival outcomes: a comprehensive meta-analysis.量化治疗延迟对乳腺癌生存结果的影响:一项全面的荟萃分析。
Geroscience. 2025 Jun 10. doi: 10.1007/s11357-025-01719-1.
3
Access to timely cancer treatment initiation in India: extent, determinants and trends.
印度及时启动癌症治疗的情况:范围、决定因素及趋势。
Lancet Reg Health Southeast Asia. 2024 Dec 18;32:100514. doi: 10.1016/j.lansea.2024.100514. eCollection 2025 Jan.
4
Comprehensive diagnosis of advanced-stage breast cancer: exploring detection methods, molecular subtypes, and demographic influences - A cross-sectional study.晚期乳腺癌的综合诊断:探索检测方法、分子亚型和人口统计学影响——一项横断面研究。
Clinics (Sao Paulo). 2024 Oct 15;79:100510. doi: 10.1016/j.clinsp.2024.100510. eCollection 2024.
5
Health care accessibility and mobility in breast cancer: a Latin American perspective.乳腺癌的医疗可及性和流动性:拉丁美洲的视角。
BMC Health Serv Res. 2024 Jun 25;24(1):764. doi: 10.1186/s12913-024-11222-6.
6
Delays in presentation, diagnosis, and treatment in Sudanese women with breast cancer: a cross-sectional study.苏丹女性乳腺癌患者就诊、诊断和治疗延误的横断面研究。
Oncologist. 2024 Jun 3;29(6):e771-e778. doi: 10.1093/oncolo/oyae066.
7
Effects of the COVID-19 pandemic on delays in diagnosis-to-treatment initiation for breast cancer in Brazil: a nationwide study.2019冠状病毒病疫情对巴西乳腺癌诊断至治疗开始延迟的影响:一项全国性研究。
Ecancermedicalscience. 2023 Jul 7;17:1570. doi: 10.3332/ecancer.2023.1570. eCollection 2023.
8
Frequency and factors associated with delay in breast cancer treatment in Brazil, according to data from the Oncology Panel, 2019-2020.根据 2019-2020 年肿瘤学专家组的数据,巴西乳腺癌治疗延迟的频率和相关因素。
Epidemiol Serv Saude. 2023;32(1):e2022563. doi: 10.1590/S2237-96222023000300004.
9
The COVID-19 Pandemic Impact on Breast Cancer Diagnosis: A Retrospective Study.COVID-19 大流行对乳腺癌诊断的影响:一项回顾性研究。
Rev Bras Ginecol Obstet. 2022 Sep;44(9):871-877. doi: 10.1055/s-0042-1749207. Epub 2022 Jun 6.